Previous close | 241.53 |
Open | 243.66 |
Bid | 245.75 x 800 |
Ask | 246.13 x 800 |
Day's range | 242.74 - 246.64 |
52-week range | 177.63 - 257.85 |
Volume | |
Avg. volume | 413,590 |
Market cap | 11.576B |
Beta (5Y monthly) | 1.16 |
PE ratio (TTM) | 44.03 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.36 (0.56%) |
Ex-dividend date | 15 Aug 2024 |
1y target est | N/A |
TFX instils optimism with its robust performance in the Interventional category and potential in Asia.
Veracyte (VCYT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TFX vs. PEN: Which Stock Is the Better Value Option?